These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20066610)

  • 21. Do sleep abnormalities and misaligned sleep/circadian rhythm patterns represent early clinical characteristics for developing psychosis in high risk populations?
    Zanini M; Castro J; Coelho FM; Bittencourt L; Bressan RA; Tufik S; Brietzke E
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2631-7. PubMed ID: 24096189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disturbances of the circadian sleep-wake rhythm after time zone changes.
    Sasaki M; Endo S
    J UOEH; 1985 Mar; 7 Suppl():141-50. PubMed ID: 4012102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schizophrenia patients with predominantly positive symptoms have more disturbed sleep-wake cycles measured by actigraphy.
    Afonso P; Brissos S; Figueira ML; Paiva T
    Psychiatry Res; 2011 Aug; 189(1):62-6. PubMed ID: 21257208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep analysis during drug-free weekends in chronic schizophrenic patients.
    Jus K; Jus A; Béland C; Bouchard M; Pires P; Fontaine P; Brunelle R
    Biol Psychiatry; 1976 Dec; 11(6):709-18. PubMed ID: 187257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms].
    Müller-Spahn F; Modell S; Thomma M
    Nervenarzt; 1992 Jul; 63(7):383-400. PubMed ID: 1354331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
    Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
    Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a selective inhibitor of type A monoamine oxidase--Lilly 51641--on behavior, sleep and circadian rhythms in depressed and schizophrenic patients.
    Carman JS; Gillin JC; Murphy DL; Weinberger DR; Kleinman JE; Bigelow LB; Wyatt RJ
    Commun Psychopharmacol; 1978; 2(6):513-23. PubMed ID: 371909
    [No Abstract]   [Full Text] [Related]  

  • 31. The suitability of actigraphy, diary data, and urinary melatonin profiles for quantitative assessment of sleep disturbances in schizophrenia: a case report.
    Wulff K; Joyce E; Middleton B; Dijk DJ; Foster RG
    Chronobiol Int; 2006; 23(1-2):485-95. PubMed ID: 16687321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meeting everyday challenges: antipsychotic therapy in the real world.
    Gorwood P
    Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S156-62. PubMed ID: 16872807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?
    Gaebel W; Frick U; Köpcke W; Linden M; Müller P; Müller-Spahn F; Pietzcker A; Tegeler J
    Br J Psychiatry Suppl; 1993 Sep; (21):8-12. PubMed ID: 8105814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Executive function in schizophrenia: what impact do antipsychotics have?
    O'Grada C; Dinan T
    Hum Psychopharmacol; 2007 Aug; 22(6):397-406. PubMed ID: 17579928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep in the elderly: normal variations and common sleep disorders.
    Ancoli-Israel S; Ayalon L; Salzman C
    Harv Rev Psychiatry; 2008; 16(5):279-86. PubMed ID: 18803103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients.
    Martin J; Jeste DV; Caliguiri MP; Patterson T; Heaton R; Ancoli-Israel S
    Schizophr Res; 2001 Jan; 47(1):77-86. PubMed ID: 11163547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A schizophrenic with non-24-hour sleep-wake syndrome.
    Tagaya H; Matsuno Y; Atsumi Y
    Jpn J Psychiatry Neurol; 1993 Jun; 47(2):441-2. PubMed ID: 7903725
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of olanzapine on slow wave sleep, sleep spindles and sleep-related memory consolidation in schizophrenia.
    Göder R; Fritzer G; Gottwald B; Lippmann B; Seeck-Hirschner M; Serafin I; Aldenhoff JB
    Pharmacopsychiatry; 2008 May; 41(3):92-9. PubMed ID: 18484550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daily variations in sleep-wake patterns and severity of psychopathology: a pilot study in community-dwelling individuals with chronic schizophrenia.
    Waters F; Sinclair C; Rock D; Jablensky A; Foster RG; Wulff K
    Psychiatry Res; 2011 May; 187(1-2):304-6. PubMed ID: 21272939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.